Colonic Polypectomy in Cirrhotic Patients With Portal Hypertension
Challenges in Colonic Polypectomy and Endoscopic Mucosal Resection in Cirrhotic Patients With Portal Hypertension: Single-Center Experience
1 other identifier
observational
60
1 country
1
Brief Summary
The goal of this retrospective cohort study is to evaluate the risk of post-polypectomy bleeding following the colonoscopy resection of lower gastrointestinal polyps in patients with liver cirrhosis with portal hypertension. The main question it aims to answer is: Does the risk of bleeding increase after colonoscopy polypectomy in patients with liver cirrhosis with portal hypertension? Participants will be subjected to polypectomy of any colonic polyps.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2024
CompletedFirst Submitted
Initial submission to the registry
January 12, 2025
CompletedFirst Posted
Study publicly available on registry
February 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedFebruary 18, 2025
February 1, 2025
5 months
January 12, 2025
February 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Immediate post polypectomy bleeding (IPPB)
During procedure
Delayed post polypectomy bleeding (DPPB)
24 hours to 14 days
Secondary Outcomes (1)
Type of polyps in patients with liver cirrhosis and portal hypertension
14 days
Other Outcomes (1)
Prediction of risk of post polypectomy bleeding
6 months
Study Arms (1)
Liver cirrhosis patients with portal hypertension and colonic polyps
Colonic polypectomy
Eligibility Criteria
Liver cirrhosis patients with evidence of portal hypertension
You may qualify if:
- All liver cirrhosis patients with portal hypertension and colonic polyps
You may not qualify if:
- Patients with platelet count less than 50,000/µL.
- Patients with hemoglobin levels less than 8 g/dL.
- Prothrombin Time more than 20 seconds.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig University Hospital
Zagazig, Sharqia Province, 44519, Egypt
Related Publications (10)
Lee S, Park SJ, Cheon JH, Kim TI, Kim WH, Kang DR, Hong SP. Child-Pugh score is an independent risk factor for immediate bleeding after colonoscopic polypectomy in liver cirrhosis. Yonsei Med J. 2014 Sep;55(5):1281-8. doi: 10.3349/ymj.2014.55.5.1281.
PMID: 25048486RESULTAmarapurkar AD, Amarapurkar D, Choksi M, Bhatt N, Amarapurkar P. Portal hypertensive polyps: distinct entity. Indian J Gastroenterol. 2013 May;32(3):195-9. doi: 10.1007/s12664-013-0324-3. Epub 2013 Mar 20.
PMID: 23512212RESULTJeon JW, Shin HP, Lee JI, Joo KR, Pack KM, Cha JM, Park JJ, Lim JU, Lim K. The risk of postpolypectomy bleeding during colonoscopy in patients with early liver cirrhosis. Surg Endosc. 2012 Nov;26(11):3258-63. doi: 10.1007/s00464-012-2334-0. Epub 2012 May 31.
PMID: 22648106RESULTHui AJ, Wong RM, Ching JY, Hung LC, Chung SC, Sung JJ. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc. 2004 Jan;59(1):44-8. doi: 10.1016/s0016-5107(03)02307-1.
PMID: 14722546RESULTGibbs DH, Opelka FG, Beck DE, Hicks TC, Timmcke AE, Gathright JB Jr. Postpolypectomy colonic hemorrhage. Dis Colon Rectum. 1996 Jul;39(7):806-10. doi: 10.1007/BF02054448.
PMID: 8674375RESULTRosen L, Bub DS, Reed JF 3rd, Nastasee SA. Hemorrhage following colonoscopic polypectomy. Dis Colon Rectum. 1993 Dec;36(12):1126-31. doi: 10.1007/BF02052261.
PMID: 8253009RESULTGiannini EG, Greco A, Marenco S, Andorno E, Valente U, Savarino V. Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. Clin Gastroenterol Hepatol. 2010 Oct;8(10):899-902; quiz e109. doi: 10.1016/j.cgh.2010.06.018. Epub 2010 Jun 30.
PMID: 20601131RESULTCocero N, Bezzi M, Martini S, Carossa S. Oral Surgical Treatment of Patients With Chronic Liver Disease: Assessments of Bleeding and Its Relationship With Thrombocytopenia and Blood Coagulation Parameters. J Oral Maxillofac Surg. 2017 Jan;75(1):28-34. doi: 10.1016/j.joms.2016.08.033. Epub 2016 Sep 2.
PMID: 27677683RESULTTripodi A. Hemostasis abnormalities in cirrhosis. Curr Opin Hematol. 2015 Sep;22(5):406-12. doi: 10.1097/MOH.0000000000000164.
PMID: 26203733RESULTMucino-Bermejo J, Carrillo-Esper R, Mendez-Sanchez N, Uribe M. Thrombosis and hemorrhage in the critically ill cirrhotic patients: five years retrospective prevalence study. Ann Hepatol. 2015 Jan-Feb;14(1):93-8.
PMID: 25536646RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ayman Sadek, MD
Zagazig University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Internal Medicine
Study Record Dates
First Submitted
January 12, 2025
First Posted
February 18, 2025
Study Start
January 14, 2024
Primary Completion
June 26, 2024
Study Completion
March 1, 2025
Last Updated
February 18, 2025
Record last verified: 2025-02